Published in J Virol on June 06, 2012
Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae. PLoS Pathog (2013) 1.16
Emergence of Highly Pathogenic Avian Influenza A(H5N1) Virus PB1-F2 Variants and Their Virulence in BALB/c Mice. J Virol (2015) 0.88
The influenza virus protein PB1-F2 interacts with IKKβ and modulates NF-κB signalling. PLoS One (2013) 0.84
The role of influenza in the severity and transmission of respiratory bacterial disease. Lancet Respir Med (2014) 0.83
Molecular signatures of virulence in the PB1-F2 proteins of H5N1 influenza viruses. Virus Res (2013) 0.82
Seasonal H3N2 influenza A virus fails to enhance Staphylococcus aureus co-infection in a non-human primate respiratory tract infection model. Virulence (2013) 0.80
Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding. Mol Immunol (2015) 0.79
Amyloid Assemblies of Influenza A Virus PB1-F2 Protein Damage Membrane and Induce Cytotoxicity. J Biol Chem (2015) 0.78
The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections. Front Microbiol (2016) 0.78
Can surveillance of the influenza virus PB1-F2 gene be used to predict the severity of secondary bacterial infections? Virulence (2012) 0.78
Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers. PLoS One (2014) 0.76
Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza. J Pharmacokinet Pharmacodyn (2016) 0.76
Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology (1998) 9.81
Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med (2009) 9.06
On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology (1978) 9.02
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe (2007) 5.46
Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep (2009) 5.25
A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog (2007) 4.99
Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science (2010) 4.92
Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol (2006) 4.74
Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis (2002) 4.21
Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med (2008) 3.67
Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog (2005) 3.44
Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun (2001) 3.28
Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis (2003) 3.12
The annual production cycle for influenza vaccine. Vaccine (2003) 3.10
A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol (2009) 2.94
Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis (2010) 2.77
The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol (2003) 2.76
IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol (2004) 2.59
Multiple reassortment between pandemic (H1N1) 2009 and endemic influenza viruses in pigs, United States. Emerg Infect Dis (2011) 2.42
Long-term evolution and transmission dynamics of swine influenza A virus. Nature (2011) 2.39
PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. J Virol (2010) 2.35
Pause on avian flu transmission research. Science (2012) 2.24
Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep (2007) 2.20
Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza Other Respir Viruses (2009) 2.11
The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol (2011) 1.95
Complications of seasonal and pandemic influenza. Crit Care Med (2010) 1.94
The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol (2008) 1.90
PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog (2010) 1.75
The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol (2010) 1.63
The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog (2011) 1.60
Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J (2010) 1.59
Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis (2011) 1.56
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine (2008) 1.55
An update on swine-origin influenza virus A/H1N1: a review. Virus Genes (2009) 1.52
A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. J Virol (2010) 1.44
Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cells. J Immunol (2010) 1.38
The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J Virol (2009) 1.29
Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors. Virology (2011) 1.28
A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. J Virol (2010) 1.22
Flu surveillance lacking. Nature (2012) 1.22
PB2 and hemagglutinin mutations are major determinants of host range and virulence in mouse-adapted influenza A virus. J Virol (2010) 1.21
The PB2-E627K mutation attenuates viruses containing the 2009 H1N1 influenza pandemic polymerase. MBio (2010) 1.18
Impact of amino acid mutations in PB2, PB1-F2, and NS1 on the replication and pathogenicity of pandemic (H1N1) 2009 influenza viruses. J Virol (2011) 1.17
Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J Virol (2010) 1.17
The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. J Virol (2011) 1.13
Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011. Euro Surveill (2011) 1.11
Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82. J Virol (2011) 1.09
The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol Chem (2011) 1.08
Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell Microbiol (2009) 1.08
Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets. J Infect Dis (2006) 1.06
Highly pathogenic H5N1 influenza viruses carry virulence determinants beyond the polybasic hemagglutinin cleavage site. PLoS One (2010) 1.05
Planning for an influenza pandemic: thinking beyond the virus. J Infect Dis (2008) 1.01
Correlates of vaccine protection from influenza and its complications. Hum Vaccin Immunother (2012) 0.99
The proapoptotic influenza A virus protein PB1-F2 forms a nonselective ion channel. PLoS One (2010) 0.96
Letter to the editor. Group A streptococcal infections during the seasonal influenza outbreak 2010/11 in South East England. Euro Surveill (2011) 0.96
Invasive bacterial infections in relation to influenza outbreaks, 2006-2010. Clin Infect Dis (2011) 0.95
Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia. Antimicrob Agents Chemother (2011) 0.92
Pathogenicity of swine influenza viruses possessing an avian or swine-origin PB2 polymerase gene evaluated in mouse and pig models. Virology (2010) 0.88
Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections. Vaccine (2011) 0.84
Severe illness from 2009 pandemic influenza A (H1N1)--Utah, 2009-10 influenza season. MMWR Morb Mortal Wkly Rep (2011) 0.83
Molecular aspects of the epidemiology of virus disease. Experientia (1987) 0.80
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med (2015) 6.04
The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med (2006) 5.94
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe (2007) 5.46
Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med (2015) 4.90
The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity (2009) 4.51
Dynamic T cell migration program provides resident memory within intestinal epithelium. J Exp Med (2010) 4.09
Gain-of-function experiments on H7N9. Science (2013) 3.67
MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis (2014) 3.64
The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature (2013) 3.60
Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med (2007) 3.57
Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis (2006) 3.28
The influenza virus gene pool in a poultry market in South central china. Virology (2003) 3.25
Influenza in migratory birds and evidence of limited intercontinental virus exchange. PLoS Pathog (2007) 2.94
Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J Virol (2005) 2.88
Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis (2010) 2.77
Identification of H2N3 influenza A viruses from swine in the United States. Proc Natl Acad Sci U S A (2007) 2.73
Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J Virol (2005) 2.56
Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. J Clin Microbiol (2003) 2.55
H3N2 influenza virus transmission from swine to turkeys, United States. Emerg Infect Dis (2004) 2.53
Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J (2004) 2.53
Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis (2005) 2.43
Multiple reassortment between pandemic (H1N1) 2009 and endemic influenza viruses in pigs, United States. Emerg Infect Dis (2011) 2.42
Long-term evolution and transmission dynamics of swine influenza A virus. Nature (2011) 2.39
Comparative sequence analysis of the symbiosis island of Mesorhizobium loti strain R7A. J Bacteriol (2002) 2.37
Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32
Influenza: emergence and control. J Virol (2004) 2.31
Pause on avian flu transmission research. Science (2012) 2.24
Adaptation of pandemic H1N1 influenza viruses in mice. J Virol (2010) 2.22
Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respir Res (2006) 2.15
Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. J Gen Virol (2005) 2.15
Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines. Proc Natl Acad Sci U S A (2005) 2.13
Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread. Proc Natl Acad Sci U S A (2008) 2.11
Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza Other Respir Viruses (2009) 2.11
Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol (2009) 2.08
Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci U S A (2011) 2.04
Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect Dis (2010) 2.01
Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin Vaccine Immunol (2006) 2.01
Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. Comp Med (2007) 1.99
Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. J Infect Dis (2009) 1.93
N-linked glycosylation attenuates H3N2 influenza viruses. J Virol (2007) 1.92
Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China. J Virol (2011) 1.85
Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. J Infect Dis (2005) 1.83
Isolation of a novel swine influenza virus from Oklahoma in 2011 which is distantly related to human influenza C viruses. PLoS Pathog (2013) 1.83
Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol (2004) 1.83
Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathog (2010) 1.81
Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol (2006) 1.78
PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog (2010) 1.75
Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load. Am J Respir Crit Care Med (2014) 1.75
Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner. J Infect Dis (2010) 1.70
Increased pathogenicity of a reassortant 2009 pandemic H1N1 influenza virus containing an H5N1 hemagglutinin. J Virol (2011) 1.69
Does pandemic A/H1N1 virus have the potential to become more pathogenic? MBio (2010) 1.68
The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model. J Virol (2009) 1.68
The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol (2010) 1.63
Evolution and ecology of influenza A viruses. Curr Top Microbiol Immunol (2014) 1.57
Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis (2011) 1.56
Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus. Vaccine (2008) 1.54
Avian influenza viruses in Korean live poultry markets and their pathogenic potential. Virology (2005) 1.54
T cell receptor αβ diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection. Sci Transl Med (2012) 1.53
Coincident ruddy turnstone migration and horseshoe crab spawning creates an ecological 'hot spot' for influenza viruses. Proc Biol Sci (2010) 1.53
The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in Egypt. PLoS One (2011) 1.51
Bacterial sinusitis and otitis media following influenza virus infection in ferrets. Infect Immun (2006) 1.51
Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis (2011) 1.49
Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. J Virol (2006) 1.48
Continuing evolution of H9 influenza viruses in Korean poultry. Virology (2006) 1.45
Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis. Pediatrics (2006) 1.45
Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine (2007) 1.45
Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathog (2007) 1.45
Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clin Infect Dis (2010) 1.44
Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59. Proc Natl Acad Sci U S A (2011) 1.43
Matrix gene of influenza a viruses isolated from wild aquatic birds: ecology and emergence of influenza a viruses. J Virol (2004) 1.41
Isolation and genetic characterization of H5N2 influenza viruses from pigs in Korea. J Virol (2009) 1.40
The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens. Virology (2006) 1.39
NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity. J Biol Chem (2006) 1.38
Genotype turnover by reassortment of replication complex genes from avian influenza A virus. J Gen Virol (2006) 1.37
Evidence of infection with H4 and H11 avian influenza viruses among Lebanese chicken growers. PLoS One (2011) 1.35
Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol (2013) 1.34
T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro. J Virol (2013) 1.34
Role of terrestrial wild birds in ecology of influenza A virus (H5N1). Emerg Infect Dis (2007) 1.33
Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model. J Virol (2010) 1.33
Establishment and lineage replacement of H6 influenza viruses in domestic ducks in southern China. J Virol (2012) 1.32
Live bird markets of Bangladesh: H9N2 viruses and the near absence of highly pathogenic H5N1 influenza. PLoS One (2011) 1.32
Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonuclease. PLoS Pathog (2012) 1.30
Complete genome sequence of a novel Newcastle disease virus strain isolated from a chicken in West Africa. J Virol (2012) 1.30
An unexpected antibody response to an engineered influenza virus modifies CD8+ T cell responses. Proc Natl Acad Sci U S A (2006) 1.29
Hidden epitopes emerge in secondary influenza virus-specific CD8+ T cell responses. J Immunol (2007) 1.28
Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses. J Virol (2005) 1.28
Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics. J Virol (2004) 1.28
Natural history of highly pathogenic avian influenza H5N1. Virus Res (2013) 1.26
Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011. J Virol (2012) 1.26
Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice. MBio (2014) 1.26
Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs. Virology (2006) 1.24
Viral reassortment and transmission after co-infection of pigs with classical H1N1 and triple-reassortant H3N2 swine influenza viruses. J Gen Virol (2010) 1.23
Traditional and new influenza vaccines. Clin Microbiol Rev (2013) 1.22
H5N1 influenza virus pathogenesis in genetically diverse mice is mediated at the level of viral load. MBio (2011) 1.22
Extent of antigenic cross-reactivity among highly pathogenic H5N1 influenza viruses. J Clin Microbiol (2011) 1.21
Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus. J Infect Dis (2008) 1.21
Influenza a virus migration and persistence in North American wild birds. PLoS Pathog (2013) 1.19
Antigenic and molecular characterization of avian influenza A(H9N2) viruses, Bangladesh. Emerg Infect Dis (2013) 1.19
Continuing threat of influenza (H5N1) virus circulation in Egypt. Emerg Infect Dis (2011) 1.18
Motivating factors for high rates of influenza vaccination among healthcare workers. Vaccine (2011) 1.18